Short-term administration of basic fibroblast growth factor enhances coronary collateral development without exacerbating atherosclerosis and balloon injury–induced vasoproliferation in atherosclerotic rabbits with acute myocardial infarction

Journal of Laboratory and Clinical Medicine - Tập 140 - Trang 119-125 - 2002
Chunxiang Zhang1, Jian Yang1, Jianzhang Feng1, Lisa K. Jennings1
1Vascular Biology Center of Excellence, University of Tennessee Health Science Center; and the World Health Organization Collaborating Center and Guangdong Cardiovascular Institute. Memphis, Tennessee

Tài liệu tham khảo

Yanagisawa-Miwa, 1992, Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor, Science, 257, 1401, 10.1126/science.1382313 Lazarous, 1995, Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart, Circulation, 91, 145, 10.1161/01.CIR.91.1.145 Batter, 1993, Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium, J Am Coll Cardiol, 22, 2001, 10.1016/0735-1097(93)90790-8 Sellke, 1998, Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results, Ann Thorac Surg, 65, 1540, 10.1016/S0003-4975(98)00340-3 Unger, 1994, Basic fibroblast growth factor enhances myocardial collateral flow in a canine model, Am J Physiol, 266, H1588 Burgess, 1989, The heparin-binding (fibroblast) growth factor family of proteins, Ann Rev Biochiem, 58, 575, 10.1146/annurev.bi.58.070189.003043 Jacot, 1996, Histological evaluation of the canine retinal vasculature following chronic systemic administration of basic fibroblast growth factor, J Anat, 188, 349 Lazarous, 1996, Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury, Circulation, 94, 1074, 10.1161/01.CIR.94.5.1074 Holman, 1958, Techniques for studying atherosclerotic lesions, Lab Invest, 7, 42 Foegh, 1994, Early inhibition of myointimal proliferation by angiopeptin after balloon catheter injury in the rabbit, J Vasc Surg, 19, 1084, 10.1016/S0741-5214(94)70221-7 Lopez, 1997, Basic fibroblast growwth factor in a porcine model of chronic myocardial ischemia: a comparison of angiographic, echocardiograph and coronary flow parameters, J Pharmacol Exp Ther, 282, 385 Harada, 1994, Basis fibroblast growth factor improves myocardial function in chronically ischemic porcine heart, J Clin Invest, 94, 623, 10.1172/JCI117378 Sabia, 1992, An association between collateral blood flow and myocardial viability in patients with recent myocardical infarction, N Engl J Med, 327, 1825, 10.1056/NEJM199212243272601 Goldberg, 1984, Functional importance of coronary collateral vessels, Am J Cardiol, 53, 694, 10.1016/0002-9149(84)90388-6 Schaper, 1976, Quantification of collateral resistance in acute and chronic experimental coronary occlusion in the dog, Circ Res, 39, 371, 10.1161/01.RES.39.3.371 Folkman, 1988, A heparin-binding angiogenic protein—basic fibroblast growth factor—is stored within basement membrane, Am J Pathol, 130, 393 Westernacher, 1995, A novel heart-derived inhhibitor of vascular cell proliferation: purification and biological activity, J Mol Cell Cardiol, 27, 1535, 10.1016/S0022-2828(95)90326-7 Rentrop, 1989, Late therombolytic therapy preserves left ventricular function in patients with collateralized total coronary occlusion: primary end-point findings of the second Mount Sinai New York University reperfusion trial, J Am Coll Cardiol, 14, 58, 10.1016/0735-1097(89)90054-5